loadpatents
Patent applications and USPTO patent grants for Mushiroda; Taisei.The latest application filed is for "modulating the aryl hydrocarbon receptor system to treat major depressive disorder".
Patent | Date |
---|---|
Modulating the aryl hydrocarbon receptor system to treat major depressive disorder Grant 11,122,997 - Ray , et al. September 21, 2 | 2021-09-21 |
Modulating The Aryl Hydrocarbon Receptor System To Treat Major Depressive Disorder App 20180098722 - Ray; Balmiki ;   et al. | 2018-04-12 |
Risk assessment for cutaneous adverse drug reactions from antiretroviral agent Grant 9,557,341 - Sungkanuparph , et al. January 31, 2 | 2017-01-31 |
Method For Diagnosing Drug Eruption Risk Induced By Antiepileptic Drug Based On Single Nucleotide Polymorphism In 21.33 Region Of Short Arm Of Chromosome 6 App 20120238455 - NAKAMURA; Yusuke ;   et al. | 2012-09-20 |
Risk Assessment For Cutaneous Adverse Drug Reactions From Antiretroviral Agent App 20110301043 - Sungkanuparph; Somnuek ;   et al. | 2011-12-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.